Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Travere Therapeutics (NASDAQ:TVTX) CEO Eric Dube Sells 60,000 Shares
Travere Therapeutics (NASDAQ:TVTX) CEO Eric Dube sold 60,000 shares of the company’s stock on April 1st for $1.856 million, reducing his stake by 12.17%. The sale was pre-arranged under a Rule 10b5-1 plan. Despite this insider selling, the stock maintains a “Moderate Buy” consensus rating from analysts with a target price of $39.00, and institutional investors like State Street and Wellington have recently increased their positions.